171 related articles for article (PubMed ID: 25561910)
1. Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods.
Homayouni A; Sadeghi F; Nokhodchi A; Varshosaz J; Afrasiabi Garekani H
Iran J Pharm Res; 2015; 14(1):35-50. PubMed ID: 25561910
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers.
Homayouni A; Sadeghi F; Nokhodchi A; Varshosaz J; Garekani HA
Iran J Basic Med Sci; 2014 May; 17(5):322-31. PubMed ID: 24967060
[TBL] [Abstract][Full Text] [Related]
3. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
4. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus.
Lavra ZM; Pereira de Santana D; Ré MI
Drug Dev Ind Pharm; 2017 Jan; 43(1):42-54. PubMed ID: 27349377
[TBL] [Abstract][Full Text] [Related]
5. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization.
Altamimi MA; Neau SH
Saudi Pharm J; 2017 Mar; 25(3):419-439. PubMed ID: 28344498
[TBL] [Abstract][Full Text] [Related]
7. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
[TBL] [Abstract][Full Text] [Related]
8. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
[TBL] [Abstract][Full Text] [Related]
9. Effect of preparation method on the surface properties and UV imaging of indomethacin solid dispersions.
Asare-Addo K; Alshafiee M; Walton K; Ward A; Totea AM; Taheri S; Mawla N; Adebisi AO; Elawad S; Diza C; Timmins P; Conway BR
Eur J Pharm Biopharm; 2019 Apr; 137():148-163. PubMed ID: 30836178
[TBL] [Abstract][Full Text] [Related]
10. Improvement in the water solubility of drugs with a solid dispersion system by spray drying and hot-melt extrusion with using the amphiphilic polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer and d-mannitol.
Ogawa N; Hiramatsu T; Suzuki R; Okamoto R; Shibagaki K; Fujita K; Takahashi C; Kawashima Y; Yamamoto H
Eur J Pharm Sci; 2018 Jan; 111():205-214. PubMed ID: 28893625
[TBL] [Abstract][Full Text] [Related]
11. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques.
Homayouni A; Sadeghi F; Varshosaz J; Afrasiabi Garekani H; Nokhodchi A
Colloids Surf B Biointerfaces; 2014 Oct; 122():591-600. PubMed ID: 25124835
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.
Dontireddy R; Crean AM
Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280
[TBL] [Abstract][Full Text] [Related]
13. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
[TBL] [Abstract][Full Text] [Related]
14. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
15. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
[TBL] [Abstract][Full Text] [Related]
16. Solid-state, triboelectrostatic and dissolution characteristics of spray-dried piroxicam-glucosamine solid dispersions.
Adebisi AO; Kaialy W; Hussain T; Al-Hamidi H; Nokhodchi A; Conway BR; Asare-Addo K
Colloids Surf B Biointerfaces; 2016 Oct; 146():841-51. PubMed ID: 27451373
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique.
Chauhan B; Shimpi S; Paradkar A
AAPS PharmSciTech; 2005 Oct; 6(3):E405-12. PubMed ID: 16353998
[TBL] [Abstract][Full Text] [Related]
18. Investigation of Dissolution Mechanism and Release Kinetics of Poorly Water-Soluble Tadalafil from Amorphous Solid Dispersions Prepared by Various Methods.
Školáková T; Slámová M; Školáková A; Kadeřábková A; Patera J; Zámostný P
Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31382377
[TBL] [Abstract][Full Text] [Related]
19. Spray-Dried Amorphous Solid Dispersions of Griseofulvin in HPC/Soluplus/SDS: Elucidating the Multifaceted Impact of SDS as a Minor Component.
Rahman M; Ahmad S; Tarabokija J; Parker N; Bilgili E
Pharmaceutics; 2020 Feb; 12(3):. PubMed ID: 32106495
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast.
Madan JR; Pawar AR; Patil RB; Awasthi R; Dua K
Polim Med; 2018; 48(1):17-24. PubMed ID: 30657654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
